National Key Account Manager - Uro-Oncology

Job Description:

At Ferring Pharmaceuticals, we help people around the world build families and live better lives. We are entrepreneurial and innovative, with a global team focused on scientific advances in the areas of reproductive and women’s health, gastroenterology and urology. Ferring + You is all about working together and sharing ideas, so that we can bring science to life for patients around the world.

Our Commercial teams collaborate as trusted partners with patient groups, clinicians, policy makers and the scientific community to identify and develop new opportunities to help patients. Customer centric, we offer an empowering, entrepreneurial culture – and a place to thrive and grow.

As part of this ambition, we continue to strengthen our presence in Uro-Oncology, building on an established portfolio and preparing for an exciting launch planned for 2027. To support this, we are shaping a lean, high-impact field team focused on enabling commercial access to an innovative intravesical gene therapy — the first of its kind to be licensed in the UK.

This role offers the opportunity to play a key part in introducing a first-in-class treatment within a focused, specialist market.

Ferring+You This is a national field-based role focused entirely on the oncology and uro-oncology market. As National Key Account Manager (KAM) will be responsible for establishing and managing relationships with the specialist urologists, oncologists and multidisciplinary teams across a defined network of private cancer centres — principally in London, Oxford, Cambridge, Surrey region and the South East, with national coverage across a further five to six regional centres.

Your primary objective is to secure and accelerate patient access by working through private medical insurers, specialist private hospital networks and self-funding patient pathways. This is not a volume-driven detailing role. It is a high-value, high-complexity key account management position requiring strategic relationship management, commercial acumen and deep understanding of how private oncology operates in the UK.You will work closely with the Commercial Lead
- Uro-Oncology on access strategy and insurer engagement, and with the Field Medical Advisor
- Uro-Oncology on clinical education and KOL development.

Your day at Ferring Account Management & Access (60%)Build, manage and develop relationships with target urologists, uro-oncologists and MDT leads across approximately 8 private specialist centres nationally

Secure formulary inclusion, prescriber engagement and patient access pathways within each target account

Navigate private hospital procurement, pharmacy and governance processes to enable product availability at launch

Identify and resolve access barriers at account level — including PMI prior authorisation requirements, pharmacy stocking and clinical governance approvals

Maintain accurate and current account plans for each target centre with clear access milestones, stakeholder maps and activity records

Private Insurer Engagement (20%)Support the Portfolio Lead in insurer engagement — providing field intelligence on insurer coverage decisions, prior authorisation outcomes and patient funding challenges

Act as the field interface between prescribing urologists and insurer medical teams where clinical justification or appeals processes are required

Gather and report real-world coverage data to inform the ongoing insurer access strategy

Commercial Execution & Reporting (10%)Track and report account-level sales activity, patient starts, insurer coverage outcomes and access milestones

Contribute to quarterly business reviews with accurate field intelligence, account-level analysis and market insight

Manage territory budget (meetings, materials, travel) within agreed parameters and compliance requirementsKOL & Clinical Stakeholder Development (10%)Identify, develop and maintain relationships with key opinion leaders in private urology and uro-oncology

Support clinical education activities, advisory boards and congress engagement in partnership with the MSLProvide field-based intelligence on clinical sentiment, competitive activity and evolving…